Oncology and Hematology Associates of Central Jersey PA joins Regional Cancer Care Associates
Leading cancer care provider Regional Cancer Care Associates (RCCA) is proud to announce that it will be adding a new
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Leading cancer care provider Regional Cancer Care Associates (RCCA) is proud to announce that it will be adding a new
Share on facebook Share on twitter Share on linkedin Share on email Share on print Patient-satisfaction ratings from the Oncology
Doctors are at the forefront of efforts to protect and enhance health, applying their expertise to lead patients through medical
Leukemia diagnoses are rising in northern New Jersey even as they fall nationwide, with Sussex and Morris counties outpacing the
While lung cancer remains the leading cause of cancer deaths, recent developments have enhanced physicians’ ability to detect the disease
Recent FDA actions have significantly expanded treatment options for women with advanced uterine cancer, according to two oncologists with Regional
A look at who is a candidate for genetic screening, and how that screening should be performed.
Three RCCA oncologists look at the factors driving this troubling trend.
The numbers are cause for awareness and proactivity, not anxiety, Dr. Levenbach explains.
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.